These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2088769)

  • 1. In vivo and in vitro pharmacokinetics and metabolism of vincaalkaloids in rat. II. Vinblastine and vincristine.
    Zhou XJ; Martin M; Placidi M; Cano JP; Rahmani R
    Eur J Drug Metab Pharmacokinet; 1990; 15(4):323-32. PubMed ID: 2088769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro pharmacokinetics and metabolism of vincaalkaloids in rat. I. Vindesine (4-deacetyl-vinblastine 3-carboxyamide).
    Rahmani R; Zhou XJ; Placidi M; Martin M; Cano JP
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):49-55. PubMed ID: 2384117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
    Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
    Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the cellular accumulation and the cytotoxicity of S12363, a new Vinca alkaloid derivative.
    Pierré A; Pérez V; Léonce S; Boutin JA; Saint-Dizier D; Hautefaye P; Lavielle G; Atassi G
    Cancer Chemother Pharmacol; 1992; 29(5):367-74. PubMed ID: 1551175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR and mass spectrometric characterization of vinblastine, vincristine and some new related impurities - part I.
    Dubrovay Z; Háda V; Béni Z; Szántay C
    J Pharm Biomed Anal; 2013 Oct; 84():293-308. PubMed ID: 22985529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
    Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
    Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of intrinsic sensitivity to Vinca alkaloids in xenografts of pediatric rhabdomyosarcomas.
    Houghton JA; Williams LG; Torrance PM; Houghton PJ
    Cancer Res; 1984 Feb; 44(2):582-90. PubMed ID: 6692363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR and mass spectrometric characterization of vinblastine, vincristine and some new related impurities--part II.
    Háda V; Dubrovay Z; Lakó-Futó A; Galambos J; Gulyás Z; Aranyi A; Szántay C
    J Pharm Biomed Anal; 2013 Oct; 84():309-22. PubMed ID: 23177164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents.
    Müller LJ; Moorer-van Delft CM; Zijl R; Roubos EW
    Cancer Res; 1990 Mar; 50(6):1924-8. PubMed ID: 2407348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vinblastine and vincristine--growth-inhibitory effects correlate with their retention by cultured Nb 2 node lymphoma cells.
    Gout PW; Noble RL; Bruchovsky N; Beer CT
    Int J Cancer; 1984 Aug; 34(2):245-8. PubMed ID: 6469399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats.
    Song S; Suzuki H; Kawai R; Sugiyama Y
    Drug Metab Dispos; 1999 Jun; 27(6):689-94. PubMed ID: 10348798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical pharmacokinetics of vinca alkaloids].
    Rahmani R; Samak R; Bore P; Cano JP
    Bull Cancer; 1988; 75(2):195-200. PubMed ID: 3359064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An HPLC method for the pharmacokinetic study of vincristine sulfate-loaded PLGA-PEG nanoparticle formulations after injection to rats.
    Chen J; He H; Li S; Shen Q
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1967-72. PubMed ID: 21665557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary excretion of vincristine.
    Jackson DV; Castle MC; Bender RA
    Clin Pharmacol Ther; 1978 Jul; 24(1):101-7. PubMed ID: 657711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats.
    Liu X; Chism JP; LeCluyse EL; Brouwer KR; Brouwer KL
    Drug Metab Dispos; 1999 Jun; 27(6):637-44. PubMed ID: 10348791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies with 4'-deoxyepivincristine (vinepidine), a semisynthetic vinca alkaloid.
    Mullin K; Houghton PJ; Houghton JA; Horowitz ME
    Biochem Pharmacol; 1985 Jun; 34(11):1975-9. PubMed ID: 4004913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between binding affinity, retention and sensitivity of human rhabdomyosarcoma xenografts to Vinca alkaloids.
    Houghton JA; Williams LG; Dodge RK; George SL; Hazelton BJ; Houghton PJ
    Biochem Pharmacol; 1987 Jan; 36(1):81-8. PubMed ID: 3541941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
    Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
    Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and excretion of (3H)vincristine in the rat and the dog.
    Castle MC; Margileth DA; Oliverio VT
    Cancer Res; 1976 Oct; 36(10):3684-9. PubMed ID: 953993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.